Autres langues Devyser Diagnostics AB

Actions

DVYSR

SE0016588867

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:24:27 10/05/2024			Varia. 5j.	Varia. 1 janv.
99,8 ^SEK	+0,81 %		-0,20 %	+26,97 %

08/05	Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024
08/05	Devyser Diagnostics AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Devyser Diagnostics Q1 - The recognition of Devyser begins	10/05
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024	08/05
Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Invitation to audiocast for Devyser’s Q1 report 2024	03/05
Devyser Receives IVDR Approval for Post-Transplant Monitoring Software	25/04
Devyser partners with Hamilton to automate laboratory NGS workflows	23/04
Devyser Diagnostics AB Enters into Co-Marketing Agreement with Hamilton Bonaduz AG	23/04
Devyser receives MDSAP certification for Brazil	16/04
Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test	11/03
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patient	29/02
Devyser Diagnostics AB Announces Study Publication Demonstrating dd-cfDNA Detection in Dual Donor Kidney Transplant Patient	29/02
Devyser Diagnostics Q4 - Better positioned than ever	21/02
Devyser Diagnostics AB publishes year-end report for January to December 2023	20/02
Devyser Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
Devyser Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	20/02
Invitation to audiocast for Devyser’s Q4 report 2023	14/02
Devyser Diagnostics AB Announces Michael Uhlin, CSO Joins Management Team as of February 1, 2024	29/01
Devyser's US Lab Inks SEK25 Million Deal with UK Diagnostics Company Cyted	17/01
Devyser Genomic Laboratories Signs First Commercial Agreement with Cyted	17/01
Sweden’s Devyser Wins SEK1.5 Million Tender in Italy for Cystic Fibrosis Test Kits	15/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Devyser Diagnostics AB

Actions

DVYSR

SE0016588867

Autres langues

Filtres